Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,144.2
-16.5 (-0.52%)

 

  • STI Straits Times Index
    3,144.2
    -16.5 (-0.52%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,566.2
    -7.9 (-0.50%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,566.7
    -219.5 (-0.82%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,941.6
    -12.8 (-0.43%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,625.4
    76.5 (0.34%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,237.4
    11.9 (0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,080.6
    -8.2 (-0.39%)
    Index delayed 20 minutes
  • XAO XAO
    6,778.2
    -0.4 (-0.01%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 631.0M
  • Value: 754.4M
  • Rise: 119
  • Fall: 170
  • Unch: 542

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SunMoonFood^0.067-0.002
Rex Intl0.096+0.001
Sembcorp Marine1.390+0.040
Golden Agri-Res0.210-
Mapletree Log Tr1.680+0.020
TEE Intl0.047+0.003
Capital World0.010-0.002
Singapore-eDev0.050-
SingTel3.240-0.020
AEM1.360+0.030

World Indices

World Indices
Name Last Change
Nasdaq 8,104.3 -58.7
HSI 26,566.7 -219.5
HSCEI 10,451.7 -75.2
Jakarta 6,235.7 +10.2
Nikkei 225 22,625.4 +76.5
SSE Comp 2,941.6 -12.8
Shanghai A 3,081.8 -13.4
Shanghai B 264.3 -1.3
PSE Comp 0.0
KOSPI 2,080.6 -8.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

BEIGENE BEIGENE
Quotes 15 Minutes Delayed. Updated at 23 Oct 2019 16:08
Last (HKD): 80.200 Change: +1.350 High: 80.950 Remarks: -
Change (%): +1.71 Low: 78.800
Open 78.850 Yesterday's Close 78.850
Buy Price 80.100 Sell Price 80.200
Buy Volume ('000) 0.1 Sell Volume ('000) 3.7
Cumulative Volume ('000) 64.8 Cumulative Value 5,177,135
 
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -6.73118 Trailing EPS (HKD) e -6.64915 NAV (HKD) b 15.4742
PE a - Trailing PE f - Price / NAV b 5.1828
Dividend (HKD) d - Cash In Hand (HKD) g 9.2963 Issued & Paid-up Shares c 784,512,000
Dividend Yield (%) d - Price / Cash In Hand g 8.627 Treasury Shares h -
Beta - 75 Daysi 0.587 R-Squared - 75 Days(%)i 5.87 Market Cap (M) 62,917.862
Beta - 500 Daysi 1.210 R-Squared - 500 Days (%)i 20.00 Enterprise Value (M) 53,077.612
Piotroski F Score 2 Exchange Code 6160 Par Value ( USD ) 0.00010
52 Weeks Volatility (%) 50.00 6-Month VWAP 78.498 Free Float (%) 89.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Aug 2018.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BEIGENE HKEx 62,917.862 - - 5.1828 -
Industry Biotechnology HKEx 50,395.734 13.409 14.209 5.6556 2.710
Local Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Local Peer SINO BIOPHARM HKEx 135,326.830 12.630 13.034 3.9757 0.680
Local Peer WUXI BIO HKEx 98,614.421 132.030 103.217 10.1512 -
Local Peer 3SBIO HKEx 34,831.312 23.025 28.025 3.4330 -
Local Peer GENSCRIPT BIO HKEx 32,603.025 196.078 - 9.1941 -
Local Peer FRONTAGE HKEx 10,058.276 114.175 114.166 5.2057 -
Local Peer VIVA BIOTECH HKEx 7,655.212 71.376 71.376 3.9743 -
Local Peer HAOHAI BIOTEC HKEx 7,698.179 15.678 17.376 1.8125 1.351
Local Peer ASCLETIS-B HKEx 3,462.932 - - 0.8984 -
Local Peer CKLIFE SCIENCES HKEx 3,315.819 12.610 12.592 0.7942 2.899
Local Peer ESSEX BIO-TECH HKEx 3,120.860 13.505 11.923 2.9678 1.168
Local Peer LEE'S PHARM HKEx 2,629.852 6.287 7.950 1.1604 2.656
Other Local Peers BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 122,836.756 14.634 15.436 11.3801 2.706
Global Peer GILEAD SCIENCES INC NASDAQ 83,408.397 15.290 14.006 3.6880 3.504
Global Peer CSL ASX 113,805.144 42.418 42.418 15.2082 1.058
Global Peer CELGENE CORP NASDAQ 74,205.183 18.340 14.078 7.3829 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 49,109.107 23.425 22.171 9.6863 -
Global Peer ILLUMINA INC NASDAQ 45,430.350 55.000 48.433 10.4871 -
Global Peer BIOGEN INC NASDAQ 51,990.076 11.734 9.820 4.0138 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,112.267 13.546 16.002 3.3941 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,114.165 73.146 21.562 4.8692 0.820
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,261.257 286.870 16.693 2.1903 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NATERA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), GENOMIC HEALTH INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), VERACYTE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), POLYNOVO LIMITED (ASX), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD (ASX), INTREXON CORP (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VANDA PHARMACE INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD (ASX), HOMOLOGY MEDICINES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), TRANSLATE BIO INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), REPLIMUNE GROUP INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), IMMUNOGEN INC (NASDAQ), XBIOTECH INC (NASDAQ), KADMON HLDGS INC (NYSE), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DERMIRA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), PERSONALIS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), AGENUS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CYMABAY THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), GERON CORP (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), GLYCOMIMETICS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), SORRENTO THERAPEUTICS INC (NASDAQ), PFENEX INC (NYSE American), CHIASMA INC (NASDAQ), KAMADA (NASDAQ), ATHERSYS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), AFFIMED N V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), AVEO PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), NANOVIRICIDES INC (NYSE American), CALITHERA BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SESEN BIO INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), JOUNCE THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PHYLOGICA LIMITED (ASX), NANTKWEST INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), FORTRESS BIOTECH INC (NASDAQ), CHIMERIX INC (NASDAQ), TREVENA INC (NASDAQ), VERASTEM INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), VACCINEX INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), IMMUTEP LTD (ASX), ARAVIVE INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CEL-SCI CORP (NYSE American), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), CURIS INC (NASDAQ), OTONOMY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CATALYST BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), PORT (SET), EQUILLIUM INC (NASDAQ), INFLARX N V (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), INMUNE BIO INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), VERMILLION INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), IMUGENE LIMITED (ASX), ORTHOCELL LIMITED (ASX), IBIO INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), IVERIC BIO INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), SURFACE ONCOLOGY INC (NASDAQ), MEMPHASYS LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), SAVARA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOTRON (ASX), ACTINOGEN MEDICAL LTD (ASX), FIBROCELL SCIENCE INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIOCARDIA INC (NASDAQ), RHINOMED LIMITED (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ORAGENICS INC (NYSE American), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), OCUGEN INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), BIOCEPT INC (NASDAQ), ISORAY INC (NYSE American), SOPHIRIS BIO INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), PATRYS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), TOCAGEN INC (NASDAQ), IMMURON LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), PRECIPIO INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), REGENEUS LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), ADALTA LTD (ASX), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ATYR PHARMA INC (NASDAQ), VAXART INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CELLMID LIMITED (ASX), BIONANO GENOMICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), ONCONOVA THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), MEGASUN (Bursa), ADVAXIS INC (NASDAQ), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), ARCA BIOPHARMA INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), REXAHN PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), AIM IMMUNOTECH INC (NYSE American), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TBG DIAGNOSTICS LTD (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), QT Vascular (SGX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CCP TECHNOLOGIES LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), NANOLLOSE LTD (ASX), NOVITA HEALTHCARE LTD (ASX), SPHERIX INC (NASDAQ), NEURALSTEM INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+6.350
+8.60 %
10 Days -+7.200
+9.86 %
20 Days --1.750
-2.14 %
Medium Term Return 3 Months -+3.450
+4.50 %
6 Months -+6.550
+8.89 %
1 Year -+10.100
+14.41 %
Annualised Return Annualised --
+14.41 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 61.050 - 94.200 Change From 1 Year Low +19.150 % Change From 1 Year Low (%) +31.37
Change From 1 Year High -14.000 % Change From 1 Year High (%) -14.86
2 Years Range 61.050 - 108.200 Change From 2 Years Low +19.150 % Change From 2 Years Low (%) +31.37
Change From 2 Years High -28.000 % Change From 2 Years High (%) -25.88
5 Years Range 61.050 - 108.200 Change From 5 Years Low +19.150 % Change From 5 Years Low (%) +31.37
Change From 5 Years High -28.000 % Change From 5 Years High (%) -25.88
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Historical Price Data

Date Open High Low Close Volume VWAP
22 Oct 2019 79.300 79.600 78.850 78.850 27,900 79.0683
21 Oct 2019 78.050 80.100 77.350 79.300 10,600 78.8910
18 Oct 2019 78.850 80.400 78.000 80.400 75,100 79.6338
17 Oct 2019 75.000 76.850 75.000 76.700 18,500 75.8811
16 Oct 2019 73.900 75.400 73.900 74.800 10,400 75.0611
15 Oct 2019 73.350 73.900 73.050 73.850 11,300 73.4575
14 Oct 2019 72.300 73.000 72.050 72.050 33,500 72.9081
11 Oct 2019 71.200 72.850 71.000 72.850 13,207 71.6312
10 Oct 2019 70.350 71.000 70.050 70.550 16,600 70.5283
09 Oct 2019 72.800 73.050 70.600 71.200 26,200 71.2042
08 Oct 2019 73.750 73.950 73.000 73.000 21,200 73.2604
04 Oct 2019 80.500 80.500 73.450 73.650 11,400 73.8763
03 Oct 2019 73.800 74.150 73.000 73.200 27,400 73.7066
02 Oct 2019 75.100 76.100 72.050 73.000 18,200 73.5978
30 Sep 2019 77.000 77.250 74.150 75.100 26,000 75.1385
27 Sep 2019 75.500 78.500 75.500 78.050 37,200 78.0200
26 Sep 2019 76.300 79.650 76.300 79.400 25,300 78.5575
25 Sep 2019 81.550 81.550 75.500 76.150 12,900 79.0915
24 Sep 2019 80.700 82.000 80.700 81.950 30,700 81.4153
23 Sep 2019 79.500 81.000 79.500 80.700 85,300 80.3633
20 Sep 2019 79.500 79.500 78.300 78.800 34,200 79.0583
19 Sep 2019 79.500 79.500 76.050 77.000 30,500 77.0051
Summary
Current 2 Weeks
(09 Oct 2019 to 22 Oct 2019)		 72.800 80.400 70.050 78.850 243,307 -
Previous 2 Weeks
(23 Sep 2019 to 08 Oct 2019)		 79.500 81.000 70.050 73.000 295,600 -
4 Weeks from
(26 Aug 2019 to 20 Sep 2019)		 85.850 86.450 70.050 78.800 1,150,601 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.